Mesothelioma.com Resources for Patients and their Families
Request Free Guide

Mesothelioma Doctors

Alice M. Boylan MD

Dr. Boylan
Charleston, SC

Dr. Alice M. Boylan

Chief, Acute, Critical, and Trauma

Medical University of South Carolina

Integrated Center of Comprehensive Excellence (ICCE)
96 Jonathan Lucas Street, Room 807B3
Charleston, SC 29425
843.792.5626

Need Help Contacting This Doctor?

Dr. Alice Boylan currently serves as cheif of Acute, Critical and Trauma at the Integrated Center of Clinical Excellence at the Medical University of South Carolina (MUSC) located in Charleston. Prior to assuming her post at MUSC in 1995, Dr. Boylan served on the faculty at the University of California San Francisco (UCSF).

Board-certified in internal medicine, pulmonary disease and critical care medicine, Dr. Boylan’s clinical expertise and research interests focus on the diagnosis and treatment of critically ill patients, including those patients with mesothelioma.

Dr. Boylan is a noted lecturer both nationally and internationally. She has been the recipient of numerous research grants over the past 20 years serving as lead investigator of these scientific and clinical endeavors.

Main Specialty: Pulmonology

Other Interests & Specialties: Pulmonary medicine, acute renal failure, benign prostatic hypertrophy, chronic renal disease, cirrhosis, cystic fibrosis, dehydration, emphysema, heart failure, obstructive sleep apnea, overweight and obesity, pneumonia, pulmonary embolism, sarcoidosis and the treatment of critically ill patients.

Certifications, Awards & Accolades: American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Certification in Critical Care Medicine, American Board of Internal Medicine Certification in Pulmonary Disease, MUSC Outstanding Clinician Award, member of the American Thoracic Society, member of the Society of Critical Care Medicine, member of the International Mesothelioma Interest Group (iMig)

Education & Experience:

Publications:
Mesothelioma: New Concepts in Diagnosis and Management. Current Opinion in Pulmonary Medicine. March 2000; 6(2):157-163.

Co-ordinated over-expression of the MRP and gamma-glutamylcysteine synthetase genes, but not MDR1, correlates with doxorubicin resistance in human malignant mesothelioma cell lines. International Journal of Medicine. March 1998;75(5):757-61.

CaSm (LSm-1) overexpression in lung cancer and mesothelioma is required for transformed phenotypes. American Journal of Respiratory Cell and Molecular Biology. June 2008;38(6):671-8. doi: 10.1165/rcmb.2007-0205OC

Author: Linda Molinari

Editor in Chief, Mesothelioma Cancer Alliance

Linda Molinari

Reviewer: Annette Charlevois

Patient Support Coordinator

Annette Charlevois
Share
Tweet
Share
Mesothelioma Treatment Guide

Free Mesothelioma Treatment Guide

Please fill in the form below to request our FREE Mesothelioma Treatment Guide. It will be sent to you within 24 hours.

Have you or someone you know been diagnosed with mesothelioma?

Get Access To: